H. R. 1193 

One Hundred Seventeenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Monday, 

the third day of January, two thousand and twenty-two 

An Act 

To amend title IV of the Public Health Service Act to direct the Director of the 

National Institutes of Health, in consultation with the Director of the National 

Heart, Lung, and Blood Institute, to establish a program under which the Director 

of the National Institutes of Health shall support or conduct research on valvular 

heart disease, and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Cardiovascular Advances in 

Research and Opportunities Legacy Act’’. 

SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES. 

(a) IN GENERAL.—The Secretary of Health and Human Services 

(referred to in this section as the ‘‘Secretary’’) shall, as appropriate, 

continue activities related to research, education, and awareness 

of valvular heart diseases. 

(b) NIH RESEARCH RELATED TO VALVULAR HEART DISEASES.— 

(1) IN GENERAL.—The Director of the National Institutes 

of Health, in consultation with the Director of the National 

Heart, Lung, and Blood Institute, may support or conduct 

research regarding valvular heart diseases. 

(2) SUPPORT FURTHER RESEARCH.—In order to improve 

information on, and understanding of, causation and risk factors for valvular heart diseases, research conducted or supported under this subsection for such diseases may include 

the following: 

(A) Use of advanced technological imaging and other 

relevant methods to generate data related to valvular heart 

diseases. 

(B) Assessing potential risk factors for sudden cardiac 

arrest or sudden cardiac death from valvular heart diseases. 

(C) Other activities, as appropriate, in order to improve 

the availability of information on, and advance research 

related to, valvular heart diseases. 

(3) MITRAL VALVE PROLAPSE WORKSHOP.—Not later than 

2 years after the date of enactment of this Act, the Director 

of the National Heart, Lung, and Blood Institute shall, as 

appropriate, convene a workshop composed of subject matter 

experts and stakeholders to identify research needs and 

opportunities to develop recommendations for the identification 

and treatment of individuals with mitral valve prolapse, 
H. R. 1193—2 

including such individuals who may be at risk for sudden 

cardiac arrest or sudden cardiac death. 

(c) PREVENTION ACTIVITIES TO IMPROVE AWARENESS OF SUDDEN

CARDIAC DEATH AS A RESULT OF VALVULAR HEART DISEASES.— 

(1) IN GENERAL.—The Secretary may carry out activities 

to increase education and awareness of valvular heart diseases 

in order to reduce the incidence of sudden cardiac death caused 

by such diseases. The Secretary may— 

(A) award grants or contracts to public or nonprofit 

private entities to carry out activities under this subsection; 

and 

(B) directly, or through grants or contracts, provide 

technical assistance with respect to such activities. 

(2) CERTAIN ACTIVITIES.—Upon availability of applicable 

data, projects carried out under paragraph (1) may include— 

(A) continuing activities at the Centers for Disease 

Control and Prevention related to valvular heart diseases; 

(B) improving the awareness of the public concerning 

any risk factors for, the symptoms of, and the public health 

impact of, valvular heart diseases; and 

(C) enhancing public health data collection and 

improving the quality of such data, as appropriate, 

regarding cardiac arrests, including cardiac arrests that 

occur outside of the hospital. 

(3) GRANT PRIORITIZATION.—The Secretary may, in 

awarding grants or entering into contracts pursuant to paragraph (1), give priority to entities seeking to carry out projects 

for populations most impacted by valvular heart diseases. 

(4) COORDINATION OF ACTIVITIES.—The Secretary shall, as 

appropriate, ensure that activities under this section are coordinated with other agencies and offices of the Department of 

Health and Human Services that carry out activities regarding 

valvular heart diseases. 

(5) BEST PRACTICES.—The Secretary shall, as applicable 

and appropriate, identify and disseminate best practices for 

relevant health care providers related to valvular heart diseases. 
H. R. 1193—3 

(d) AUTHORIZATION OF APPROPRIATIONS.—For purposes of carrying out this section, there are authorized to be appropriated 

$28,000,000 for each of fiscal years 2023 through 2027. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.